R.PR
REGISTERED-PRINCIPAL REGISTER
23/11/2021
Voltar para busca
Dado oficial do USPTO
EXPRESS SCRIPTS MEDRX MANAGEMENT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Snapshot rápido
EXPRESS SCRIPTS MEDRX MANAGEMENT
ST13
US500000090251268Classe
35, 36, 44
Pedido
90251268
Registro
6570794
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
23/11/2021
Tipo de marca
Verbal
Classes Nice
35, 36, 44
Data de depósito
13/10/2020
Data de registro
23/11/2021
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/11/2021
Última transação
23/11/2021
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
01/01/2021
Primeiro uso no comércio
01/01/2021
Código do desenho
4
Tipo de titular
03
Localização do titular
St. Louis, MO
Examinador
CALLERY, TIMOTHY
Unidade examinadora
N30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Express Scripts Strategic Development, Inc.
Representantes
Troy E. Larson CIGNA INTELLECTUAL PROPERTY, INC.
Classificação técnica
Classes Nice
Classe 35Classe 36Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Drug utilization review services and prescription drug cost management services; pharmaceutical cost management services; strategic business analysis and business advice regarding pharmacy benefit managementpharmaceutical end-user behaviorhealthcare use behavior; market study and market analysis of healthcarehealthcare benefitspharmacy benefits effecting health behavior change and choice at the patient level; providing business intelligence services in the fields of pharmacy benefit managementnegotiating rebates and discounts with drug manufacturersto be used by member populations of pharmacy benefit management clients; cost management for prescription drug benefit plans of others in the field of pharmaceuticals; business servicesprescription drug cost management services
Classe 36
Pharmacy benefit management services; pharmacy benefit management consulting services; medical benefit management services; advisory services and consultancy regarding healthcare benefits and pharmacy benefits; provision of information and analysis in the fields of healthcare plan benefits and pharmacy benefits; Medicare prescription coverage plans servicesproviding insurance underwriting and claims administration of Medicare prescription drug plans for qualified beneficiaries; administration of pharmacy benefit plans; pharmacy benefit management servicestrackingmonitoringassessing and analyzing information and statistics regarding patient prescription drug use and healthcare habitsproviding a predictive model to determine patients' future prescription drug and healthcare habitsall to identify potential cost savings and for clinical benefits
Classe 44
Advisory services and consultancy regarding healthcare; healthcare serviceswellness and disease management programs; medicare prescription coverage plan servicesdisease management programs and complex case management services in the nature of providing health consultation services to patients with chronic conditions regarding medication complianceproviding information regarding health and safety issues regarding chronic conditions; providing medical information and analysis in the fields of healthcarepharmaceuticals; providing information in the field of healthcare as provided to pharmacy benefit management services clientsconsultants and brokers
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
19/10/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
18/10/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/10/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/10/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
15/10/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/10/2021
DRRR
DIVISIONAL REQUEST RECEIVED
04/10/2021
IUAF
USE AMENDMENT FILED
28/09/2021
EISU
TEAS STATEMENT OF USE RECEIVED
28/09/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/06/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/04/2021
PUBO
PUBLISHED FOR OPPOSITION
06/04/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/03/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/03/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/02/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/02/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
25/02/2021
CEPE
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
15/12/2020
ALIE
ASSIGNED TO LIE
15/12/2020
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
14/12/2020
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
14/12/2020
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
14/12/2020
DOCK
ASSIGNED TO EXAMINER
01/12/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/11/2020
NWAP
NEW APPLICATION ENTERED
16/10/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EXPRESS SCRIPTS MEDRX MANAGEMENT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.